首页> 外文OA文献 >PCN1 CHEMOTHERAPY INDUCED NAUSEA AND VOMITING EVENT RATE AMONG PATIENTS WITH CANCER TREATED WITH HIGHLY OR MODERATELY EMETOGENIC CHEMOTHERAPY AND INITIATED ON PALONOSETRON VERSUS OTHER 5-HT3-RECEPTOR ANTAGONIST ANTI-EMETIC PROPHYLAXIS IN A HOSPITAL OUTPATIENT SETTING

【2h】

PCN1 CHEMOTHERAPY INDUCED NAUSEA AND VOMITING EVENT RATE AMONG PATIENTS WITH CANCER TREATED WITH HIGHLY OR MODERATELY EMETOGENIC CHEMOTHERAPY AND INITIATED ON PALONOSETRON VERSUS OTHER 5-HT3-RECEPTOR ANTAGONIST ANTI-EMETIC PROPHYLAXIS IN A HOSPITAL OUTPATIENT SETTING

机译：PCN1化疗可诱发恶性肿瘤，并在接受高度或中度致癌化学治疗的癌症患者中呕吐事件发生率，并通过古洛酮组与其他5-HT3-受体拮抗剂在医院进行的拮抗剂治疗相关。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Craver C.; Gayle J.; Balu S.; Buchner D.;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Chemotherapy-induced nausea and vomiting and antiemetic prophylaxis with palonosetron versus other 5-HT3 receptor antagonists in patients with cancer treated with low emetogenic chemotherapy in a hospital outpatient setting in the United States [J] . SchwartzbergL., MorrowG., BaluS., Current medical research and opinion . 2011,第8期

机译：在美国医院门诊患者中，用帕洛诺司琼与其他5-HT3受体拮抗剂进行化学疗法诱导的恶心，呕吐和止吐预防
2. Randomized phase III trial of APF530 versus palonosetron in the prevention of chemotherapy-induced nausea and vomiting in a subset of patients with breast cancer receiving moderately or highly emetogenic chemotherapy [J] . Ralph Boccia, Erin O’Boyle, William Cooper BMC Cancer . 2016,第1期

机译：APF530与帕洛诺司琼在预防中度或高度致呕性化疗的部分乳腺癌患者中化疗引起的恶心和呕吐的预防性随机III期试验
3. Palonosetron versus ondansetron for prevention of chemotherapy-induced nausea and vomiting in paediatric patients with cancer receiving moderately or highly emetogenic chemotherapy: a randomised, phase 3, double-blind, double-dummy, non-inferiority study [J] . Kovacs Gabor, Wachtel Antonio E., Basharova Elena V., The lancet oncology . 2016,第3期

机译：帕洛诺司琼与恩丹西酮预防在接受中度或高度呕吐化疗的小儿癌症患者中化疗引起的恶心和呕吐：一项随机，三期，双盲，双假性，非自卑性研究
4. The Effect of Acupressure Wristbands Toward Acute Nausea and Vomiting on Post-Chemotherapy Cervix Cancer Patient in Prof. Dr. Margono Soekarjo Hospital Purwokerto [C] . Efita Yulianasari, Siti Haniyah, Indri Heri Susanti International Conference on Community Health . 2020

机译：Acu压抑腕带对急性恶心的影响，呕吐在化疗后宫颈癌患者Margono Soekarjo医院Purwokerto博士
5. Randomized phase III trial of APF530 versus palonosetron in the prevention of chemotherapy-induced nausea and vomiting in a subset of patients with breast cancer receiving moderately or highly emetogenic chemotherapy [O] . Ralph Boccia, Erin O’Boyle, William Cooper 2016

机译：APF530与帕洛诺司琼在预防中度或高度致呕性化疗的部分乳腺癌患者中化疗引起的恶心和呕吐的预防性随机III期试验
6. PCN2 PALONOSETRON VERSUS OTHER 5-HT3-RECEPTOR ANTAGONISTS IN PREVENTING CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN PATIENTS WITH CANCER TREATED IN A HOSPITAL OUTPATIENT SETTING [O] . Craver C, Gayle J, Balu S, 2010

机译：PCN2 PALONOSETRON与其他5-HT3-受体拮抗剂在医院门诊治疗的癌症患者中预防化学诱导的恶心和呕吐

PCN1 CHEMOTHERAPY INDUCED NAUSEA AND VOMITING EVENT RATE AMONG PATIENTS WITH CANCER TREATED WITH HIGHLY OR MODERATELY EMETOGENIC CHEMOTHERAPY AND INITIATED ON PALONOSETRON VERSUS OTHER 5-HT3-RECEPTOR ANTAGONIST ANTI-EMETIC PROPHYLAXIS IN A HOSPITAL OUTPATIENT SETTING

著录项

相似文献

相关主题

期刊订阅